Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clemastine Treatment in Individuals With Williams Syndrome- a Double-blind Placebo Control to Assess the Safety and Efficacy

NCT06087757 is registered in ClinicalTrials.gov with Sheba Medical Center as lead sponsor.

NCT NCT06087757
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06087757 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clemastine Treatment in Individuals With Williams Syndrome- a Double-blind Placebo Control to Assess the Safety and Efficacy
Lead sponsor
Sheba Medical Center
Phase
Phase 2
Overall status
Active, not recruiting
Start date
April 1, 2024
Completion date
July 31, 2026
Enrollment
30 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

williams syndrome